NASDAQ · Drug Manufacturers - Specialty & Generic

AMPH (AMPH) Stock

$20.22 +1.40% NASDAQ: AMPH Healthcare

Valuation

MetricValue
Price$20.22
Market Cap$891.56M
P/E Ratio12.02
P/B Ratio1.15
P/S Ratio1.22
EPS (TTM)$1.61
52-Week High$31.26
52-Week Low$16.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.39%
ROA5.34%
ROCE17.74%
Gross Margin47.34%
Operating Margin16.20%
Net Margin11.00%
Debt/Equity0.89
Current Ratio4.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$438.0M$499.0M$644.0M$732.0M$720.0M
Operating Profit$70.0M$107.0M$197.0M$205.0M$140.0M
Net Profit$62.0M$91.0M$138.0M$160.0M$98.0M
EPS$1.25$1.74$2.60$3.06$2.03
Op Margin16.0%21.5%30.6%28.1%19.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$672.0M$742.0M$1.5B$1.6B$1.6B
Total Liabilities$226.0M$213.0M$873.0M$845.0M$840.0M
Cash$126.0M$156.0M$144.0M$152.0M$170.0M
Borrowings$105.0M$103.0M$624.0M$651.0M$656.0M

Latest News

AMPH: Lowering target price to $18.00 Argus Research · Jul 15, 2026 1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges StockStory · Jul 10, 2026 BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last? Zacks · Jul 10, 2026 Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility MT Newswires · Jul 8, 2026 BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns Investing.com · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$98.0M$89.0M$184.0M$213.0M$156.0M
Investing Cash Flow$-56.0M$-57.0M$-687.0M$-166.0M$-105.0M
Financing Cash Flow$-69.0M$-25.0M$-72.0M$-91.0M$-76.0M
Net Cash Flow$32.0M$30.0M$-12.0M$7.0M$19.0M
Free Cash Flow$71.0M$65.0M$145.0M$172.0M$121.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.81
EV / EBITDA6.49
FCF Yield15.35%
Quick Ratio2.82
Interest Coverage5.60
Return 1Y-16.62%
Return 3Y-68.90%
Return 5Y-6.04%

Ownership

Insiders Held29.74%
Institutions Held77.27%
Institutions Float Held109.98%
Institutional HolderSharesReport Date
Blackrock Inc.5,421,3432026-03-31
Dimensional Fund Advisors LP2,027,9472026-03-31
State Street Corporation1,607,5152026-03-31
Vanguard Capital Management LLC1,543,6552026-03-31
TD Asset Management, Inc1,541,0442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALKS $50.71 -3.84% 25.87 $8.45B 0.00%
ANGO $14.63 +2.02% -14.36 $604.69M 0.00%
ANIP $82.63 +3.44% 24.92 $1.88B 0.00%
COLL $35.58 +0.54% 17.33 $1.15B 0.00%
EGRXEagle Pharmaceuticals, Inc. $0.37 -15.91% 0.13 $4.87M 0.00%

About AMPH

AMPH is led by CEO Yongfeng Zhang, employs 2,028 people, headquartered in US, publicly traded since 2014.

AMPH stock trades at $20.22 with a market capitalization of $891.56M. The stock is valued at a price-to-earnings (P/E) ratio of 12.02, price-to-book of 1.15, price-to-sales of 1.22. Over the past 52 weeks the stock has ranged between $16.65 and $31.26, and currently trades 35.3% below its 52-week high.

On profitability, AMPH generates a return on equity (ROE) of 10.39%, return on capital employed of 17.74%, an operating margin of 16.20%, a net profit margin of 11.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides